跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,883 条关于
“Arkin Bio Capital”
全部
8,883
临床试验
3,060
药物
1,042
机构
375
资讯
4,406
6个月前
Crossbow Therapeutics Secures $77 Million Series B to Advance TCR-Mimetic Cancer Immunotherapies
去年
Newleos Launches with $94M Series A and Roche's CNS Portfolio to Target Mental Health Disorders
28天前
Werewolf and Ambros Therapeutics Announce Merger to Advance Neridronate as Potential First FDA-Approved Treatment for CRPS-1
去年
Bluebird Bio Goes Private in $29M Deal with Carlyle and SK Capital Partners
上个月
Activation Capital Expands Virginia Bio+Tech Center, Doubling Wet Lab Capacity to Accelerate Life Sciences Commercialization
去年
Carlyle and SK Capital Complete $3-5 Per Share Acquisition of Gene Therapy Pioneer bluebird bio
去年
IGM Biosciences Downgraded by BMO Capital Following Strategic Update
5个月前
Sol-Gel Secures Patent Extension for Patidegib Until 2044, Raises $33.1M to Advance Gorlin Syndrome Trial
去年
Faron Pharmaceuticals' Bexmarilimab Shows Promise in Myelodysplastic Syndrome Treatment
9个月前
Ambros Therapeutics Launches with $125M to Advance Non-Opioid Pain Drug Neridronate for Rare Disease CRPS-1
第 1 页,共 441 页
上一页
下一页